Editas Medicine, Inc. EDIT

Full chart Compare
Set alert

Price alert · EDIT

All alert types
2.60 USD +0.03 (+1.17%)

At closeNov 3, 2026, 4:01 PM EST

2.60 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

2.57 Day range 2.71
1.66 52-week range 3.94
YTD
+26.83%
1 year
-15.03%

Revenue & Expenses

Revenue → Gross Profit: $40.52MGross Profit → Expenses: $40.52MExpenses → Selling, General & Admin: $49.90MExpenses → Research & Development: $89.95MExpenses → Interest Expense: $6.17MExpenses → Other Expenses: $54.55MNet Loss → Expenses: $160.06MGross Profit$40.52MNet Loss$160.06MExpenses$200.58MSelling, General & Admin$49.90MResearch & Development$89.95MInterest Expense$6.17MOther Expenses$54.55MRevenue$40.52M

Latest period ending Dec 31, 2025 · select a line to chart its full history

EDIT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
40.52M32.31M78.12M19.71M25.54M
40.52M32.31M78.12M19.71M25.54M
-160.01M-251.15M-169.18M-225.95M-193.15M
-160.06M-237.09M-153.22M-220.43M-192.50M
-1.80-2.88-2.02-3.21-2.85
EDIT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
146.65M131.54M123.65M141.52M203.52M
186.53M341.59M499.15M514.32M677.48M
159.25M207.31M150.06M153.64M123.84M
76.71M92.47M36.54M43.95M26.38M
27.29M134.27M349.10M360.68M553.64M
EDIT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-165.24M-210.28M-132.18M-177.35M-163.80M
138.67M162.15M-3.73M114.07M-54.47M
40.47M56.03M118.04M1.28M282.11M
-338.00K-8.83M-4.72M-4.10M-7.98M
13.90M7.89M-17.87M-62.00M63.84M